Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026

Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning (“ML”) platform with multiple clinical stage drug programs, today announced that Lantern management will be presen…